P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance

International Journal for Parasitology: Drugs and Drug Resistance

Volumn 2, Issue , 2012, Pages 58-75

  Lespine, Anne ^a   Ménez, Cécile ^a   Bourguinat, Catherine ^b   Prichard, Roger K ^b  

^a TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Anthelmintic resistance; Macrocyclic lactones; Multidrug ABC transporters; P glycoproteins

Indexed keywords

ABAMECTIN; ALBENDAZOLE; ANTHELMINTIC AGENT; AVERMECTIN; AZITHROMYCIN; BENZIMIDAZOLE; BREAST CANCER RESISTANCE PROTEIN; CLOSANTEL; DANOFLOXACIN; DORAMECTIN; EPRINOMECTIN; ITRACONAZOLE; IVERMECTIN; KETOCONAZOLE; LOPERAMIDE; MOXIDECTIN; MULTIDRUG RESISTANCE PROTEIN; QUERCETIN; RAFOXANIDE; SELAMECTIN; SPINOSAD; TRICLABENDAZOLE; VALSPODAR; VERAPAMIL;

ALLELE; APOPTOSIS; CAENORHABDITIS ELEGANS; CROSS RESISTANCE; DIROFILARIA IMMITIS; DRUG ACTIVATION; DRUG EFFICACY; DRUG INACTIVATION; DRUG METABOLISM; DRUG TRANSPORT; GENE EXPRESSION; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HAEMONCHUS CONTORTUS; HUMAN; LYMPHATIC FILARIASIS; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TELADORSAGIA CIRCUMCINCTA;

EID: 84860461870     PISSN: 22113207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpddr.2011.10.001     Document Type: Review

References (188)

1. Alvinerie M., Dupuy J., Eeckhoutte C., Sutra J.F. Enhanced absorption of pour-on ivermectin formulation in rats by co-administration of the multidrug-resistant-reversing agent verapamil. Parasitol Res. 1999, 85:920-922.
2. Alvinerie M., Dupuy J., Kiki-Mvouaka S., Sutra J.F., Lespine A. Ketoconazole increases the plasma levels of ivermectin in sheep. Vet. Parasitol. 2008, 157:117-122.
3. Ameyaw M.M., Regateiro F., Li T., Liu X., Tariq M., Mobarek A., Thornton N., Folayan G.O., Githang'a J., Indalo A., Ofori-Adjei D., Price-Evans D.A., McLeod H.L. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. Pharmacogenetics 2001, 11:217-221.
4. Amsden G.W., Gregory T.B., Michalak C.A., Glue P., Knirsch C.A. Pharmacokinetics of azithromycin and the combination of ivermectin and albendazole when administered alone and concurrently in healthy volunteers. Am. J. Trop. Med. Hyg. 2007, 76:1153-1157.
5. Ardelli B.F., Prichard R.K. Identification of variant ABC-transporter genes among Onchocerca volvulus collected from ivermectin-treated and untreated patients in Ghana, West Africa. Ann. Trop. Med. Parasitol. 2004, 98:371-384.
6. Ardelli B.F., Prichard R.K. Reduced genetic variation of an Onchocerca volvulus ABC transporter gene following treatment with ivermectin. Trans. R. Soc. Trop. Med. Hyg. 2007, 101:1223-1232.
7. Ardelli B.F., Prichard R.K. Effects of ivermectin and moxidectin on the transcription of genes coding for multidrug resistance associated proteins and behaviour in Caenorhabditis elegans. J. Nemato. 2008, 40:290-298.
8. Ardelli B.F., Guerriero S.B., Prichard R.K. Genomic organization and effects of ivermectin selection on Onchocerca volvulus P-glycoprotein. Mol. Biochem. Parasitol. 2005, 143:58-66.
9. Ardelli B.F., Guerriero S.B., Prichard R.K. Ivermectin imposes selection pressure on P-glycoprotein from Onchocerca volvulus: linkage disequilibrium and genotype diversity. Parasitology 2006, 132:375-386.
10. Ardelli B.F., Guerriero S.B., Prichard R.K. Characterization of a half-size ATP-binding cassette transporter gene which may be a useful marker for ivermectin selection in Onchocerca volvulus. Mol. Biochem. Parasitol. 2006, 145:94-100.
11. Ardelli B.F., Stitt L.E., Tompkins J.B. Inventory and analysis of ATP-binding cassette (ABC) systems in Brugia malayi. Parasitology 2010, 137:1195-1212.
12. Awadzi K., Boakye D.A., Edwards G., Opoku N.O., Attah S.K., Osei-Atweneboana M.Y., Lazdins-Helds J.K., Ardrey A.E., Addy E.T., Quartey B.T., Ahmed K., Boatin B.A., Soumbey-Alley E.W. An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann. Trop. Med. Parasitol. 2004, 98:231-249.
13. Awadzi K., Edwards G., Opoku N.O., Ardrey A.E., Favager S., Addy E.T., Attah S.K., Yamuah L.K., Quartey B.T. The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus. Ann. Trop. Med. Parasitol. 2004, 98:595-614.
14. Baker E.K., Johnstone R.W., Zalcberg J.R., El-Osta A. Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs. Oncogene 2005, 24:8061-8075.
15. Ballent M., Lifschitz A., Virkel G., Sallovitz J., Lanusse C. Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments. Drug Metab. Dispos. 2006, 34:457-463.
16. Ballent M., Lifschitz A., Virkel G., Sallovitz J., Lanusse C. Involvement of P-glycoprotein on ivermectin kinetic behaviour in sheep: itraconazole-mediated changes on gastrointestinal disposition. J Vet Pharmacol Ther. 2007, 30:242-248.
17. Bartley D.J., McAllister H., Bartley Y., Dupuy J., Menez C., Alvinerie M., Jackson F., Lespine A. P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus. Parasitology 2009, 136:1081-1088.
18. Batrakova E.V., Miller D.W., Li S., Alakhov V.Y., Kabanov A.V., Elmquist W.F. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. J. Pharmacol. Exp. Ther. 2001, 296:551-557.
19. Batrakova E.V., Li S., Alakhov V.Y., Elmquist W.F., Miller D.W., Kabanov A.V. Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85. Pharm. Res. 2003, 20:1581-1590.
20. Beech R.N., Skuce P., Bartley D.J., Martin R.J., Prichard R.K., Gilleard J.S. Anthelmintic resistance: markers for resistance, or susceptibility?. Parasitology 2011, 138(2):160-174.
21. Beugnet F., Gauthey M., Kerboeuf D. Partial in vitro reversal of benzimidazole resistance by the free-living stages of Haemonchus contortus with verapamil. Vet. Rec. 1997, 141:575-576.
22. Blackhall W.J., Liu H.Y., Xu M., Prichard R.K., Beech R.N. Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus. Mol. Biochem. Parasitol. 1998, 95:193-201.
23. Blackhall W.J., Prichard R.K., Beech R.N. P-glycoprotein selection in strains of Haemonchus contortus resistant to benzimidazoles. Vet. Parasitol. 2008, 152:101-107.
24. Blagburn B.L., Dillon A.R., Arther R.G., Butler J.M., Newton J.C. Comparative efficacy of four commercially available heartworm preventive products against the MP3 laboratory strain of Dirofilaria immitis. Vet. Parasitol. 2011, 176:189-194.
25. Borgsteede F.H., Taylor S.M., Gaasenbeek C.P., Couper A., Cromie L. The efficacy of an ivermectin/closantel injection against experimentally induced infections and field infections with gastrointestinal nematodes and liver fluke in cattle. Vet. Parasitol. 2008, 155:235-241.
26. Borst P., Evers R., Kool M., Wijnholds J. The multidrug resistance protein family. Biochim. Biophys. Acta 1999, 1461:347-357.
27. Botros S., Bennett J.L. Praziquantel resistance. Curr. Opin. Drug Discov. 2007, 2:35-40.
28. Boulin T., Fauvin A., Charvet C., Cortet J., Cabaret J., Bessereau J.L., Neveu C. Functional reconstitution of Haemonchus contortus acetylcholine receptors in Xenopus Oocytes provides mechanistic insights into levamisole resistance. Br. J. Pharmacol. 2011.
29. Bourguinat C., Pion S.D., Kamgno J., Gardon J., Duke B.O., Boussinesq M., Prichard R.K. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Negl. Trop. Dis. 2007, 1:e72.
30. Bourguinat C., Ardelli B.F., Pion S.D., Kamgno J., Gardon J., Duke B.O., Boussinesq M., Prichard R.K. P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus. Mol. Biochem. Parasitol 2008, 158:101-111.
31. Bourguinat C., Kamgno J., Boussinesq M., Mackenzie C.D., Prichard R.K., Geary T.G. Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event. Am. J. Trop. Med. Hyg. 2010, 83:28-32.
32. Bourguinat C., Keller K., Bhan A., Peregrine A., Geary T., Prichard R. Macrocyclic lactone resistance in Dirofilaria immitis. Vet. Parasitol 2011.
33. Bourguinat C., Keller K., Blagburn B., Schenker R., Geary T.G., Prichard R.K. Correlation between loss of efficacy of macrocyclic lactone heartworm anthelmintics and P-glycoprotein genotype. Vet. Parasitol. 2011, 176:374-381.
34. Brayden D.J., Griffin J. Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers. Vet. Res. Commun. 2008, 32:93-106.
35. Broeks A., Janssen H.W., Calafat J., Plasterk R.H. A P-glycoprotein protects Caenorhabditis elegans against natural toxins. EMBO J. 1995, 14:1858-1866.
36. Broeks A., Gerrard B., Allikmets R., Dean M., Plasterk R.H. Homologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans. EMBO J. 1996, 15:6132-6143.
37. Buxton S., Neveu C., Charvet C., Robertson A., Martin R. On the mode of action of emodepside: slow effects on membrane potential and voltage-activated currents in Ascaris suum. Br. J. Pharmacol. 2011, 164:453-470.
38. Chin K.V., Chauhan S.S., Pastan I., Gottesman M.M. Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells. Cell Growth Differ. 1990, 1:361-365.
39. Cisternino S., Mercier C., Bourasset F., Roux F., Scherrmann J.M. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res. 2004, 64:3296-3301.
40. Coles G.C., Jackson F., Pomroy W.E., Prichard R.K., von Samson-Himmelstjerna G., Silvestre A., Taylor M.A., Vercruysse J. The detection of anthelmintic resistance in nematodes of veterinary importance. Vet. Parasitol. 2006, 136:167-185.
41. Constantinides P.P., Wasan K.M. Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies. J. Pharm. Sci. 2007, 96:235-248.
42. Cooray H.C., Blackmore C.G., Maskell L., Barrand M.A. Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport 2002, 13:2059-2063.
43. Cornaire G., Woodley J., Hermann P., Cloarec A., Arellano C., Houin G. Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int. J. Pharm. 2004, 278:119-131.
44. Cromie L., Ferry M., Couper A., Fields C., Taylor S.M. Pharmacokinetics of a novel closantel/ivermectin injection in cattle. J. Vet. Pharmacol. Ther. 2006, 29:205-211.
45. Cully D.F., Vassilatis D.K., Liu K.K., Paress P.S., Van der Ploeg L.H., Schaeffer J.M., Arena J.P. Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature 1994, 371:707-711.
46. Dano K. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim. Biophys. Acta. 1973, 323:466-483.
47. Demeler J., Van Zeveren A.M., Kleinschmidt N., Vercruysse J., Hoglund J., Koopmann R., Cabaret J., Claerebout E., Areskog M., von Samson-Himmelstjerna G. Monitoring the efficacy of ivermectin and albendazole against gastro intestinal nematodes of cattle in Northern Europe. Vet. Parasitol. 2009, 160:109-115.
48. Dicker A.J., Nath M., Yaga R., Nisbet A.J., Lainson F.A., Gilleard J.S., Skuce P.J. Teladorsagia circumcincta: the transcriptomic response of a multi-drug-resistant isolate to ivermectin exposure in vitro. Exp. Parasitol. 2011, 127:351-356.
49. Dicker A.J., Nisbet A.J., Skuce P.J. Gene expression changes in a P-glycoprotein (Tci-pgp-9) putatively associated with ivermectin resistance in Teladorsagia circumcincta. Int. J. Parasitol 2011.
50. Didier A.D., Loor F. The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor. Anticancer Drugs 1996, 7:745-751.
51. Doyle L.A., Ross D.D. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 2003, 22:7340-7358.
52. Drogemuller M., Schnieder T., von Samson-Himmelstjerna G. Beta-tubulin complementary DNA sequence variations observed between cyathostomins from benzimidazole-susceptible and -resistant populations. J. Parasitol. 2004, 90:868-870.
53. Dunn S.T., Hedges L., Sampson K.E., Lai Y., Mahabir S., Balogh L., Locuson C.W. Pharmacokinetic interaction of the antiparasitic agents ivermectin and spinosad in dogs. Drug Metab. Dispos. 2011, 39:789-795.
54. Dupuy J., Alvinerie M., Menez C., Lespine A. Interaction of anthelmintic drugs with P-glycoprotein in recombinant LLC-PK1-mdr1a cells. Chem. Biol. Interact. 2010, 186:280-286.
55. Dupuy J., Larrieu G., Sutra J.F., Lespine A., Alvinerie M. Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Vet Parasitol. 2003, 112:337-347.
56. El-Abdellati A., De Graef J., Van Zeveren A., Donnan A., Skuce P., Walsh T., Wolstenholme A., Tait A., Vercruysse J., Claerebout E., Geldhof P. Altered avr-14B gene transcription patterns in ivermectin-resistant isolates of the cattle parasites, Cooperia oncophora and Ostertagia ostertagi. Int. J. Parasitol. 2011, 41:951-957.
57. El-Banna H.A., Goudah A., El-Zorba H., Abd-El-Rahman S. Comparative pharmacokinetics of ivermectin alone and a novel formulation of ivermectin and rafoxanide in calves and sheep. Parasitol. Res. 2008, 102:1337-1342.
58. Eneroth A., Astrom E., Hoogstraate J., Schrenk D., Conrad S., Kauffmann H.M., Gjellan K. Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction. Eur. J. Pharm. Sci. 2001, 12:205-214.
59. Eng J.K., Prichard R.K. A comparison of genetic polymorphism in populations of Onchocerca volvulus from untreated- and ivermectin-treated patients. Mol. Biochem. Parasitol. 2005, 142:193-202.
60. Eng J.K., Blackhall W.J., Osei-Atweneboana M.Y., Bourguinat C., Galazzo D., Beech R.N., Unnasch T.R., Awadzi K., Lubega G.W., Prichard R.K. Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus. Mol. Biochem. Parasitol. 2006, 150:229-235.
61. Fallon D.G., Doenhoff M.J. Drug resistant schistosomiasis:resistance to praziquantel and oxamniquine induced in schistosoma mansoni in mice is drug. J. Trop. Med. Hyg. 1994, 51:83-88.
62. Fung K.L., Gottesman M.M. A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim. Biophys. Acta 2009, 1794:860-871.
63. Gao A., Wang X., Xiang W., Liang H., Gao J., Yan Y. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin. J. Pharm. Pharmacol. 2010, 62:393-399.
64. Gao A., Liang H., Wang X., Zhang X., Jing M., Zhang J., Yan Y., Xiang W. Reversal effects of two new milbemycin compounds on multidrug resistance in MCF-7/adr cells in vitro. Eur. J. Pharmacol. 2011, 659:108-113.
65. Gasbarre L.C., Smith L.L., Lichtenfels J.R., Pilitt P.A. The identification of cattle nematode parasites resistant to multiple classes of anthelmintics in a commercial cattle population in the US. Vet. Parasitol. 2009, 166:281-285.
66. Geary T.G., Woo K., McCarthy J.S., Mackenzie C.D., Horton J., Prichard R.K., de Silva N.R., Olliaro P.L., Lazdins-Helds J.K., Engels D.A., Bundy D.A. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int. J. Parasitol. 2010, 40:1-13.
67. Georges E. The P-glycoprotein (ABCB1) linker domain encodes high-affinity binding sequences to alpha- and beta-tubulins. Biochemistry 2007, 46:7337-7342.
68. Ghisi M., Kaminsky R., Maser P. Phenotyping and genotyping of Haemonchus contortus isolates reveals a new putative candidate mutation for benzimidazole resistance in nematodes. Vet. Parasitol. 2007, 144:313-320.
69. Gomez-Martinez A., Garcia-Morales P., Carrato A., Castro-Galache M.D., Soto J.L., Carrasco-Garcia E., Garcia-Bautista M., Guaraz P., Ferragut J.A., Saceda M. Post-transcriptional regulation of P-glycoprotein expression in cancer cell lines. Mol. Cancer Res. 2007, 5:641-653.
70. Gottesman M.M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 1993, 62:385-427.
71. Griffin J., Fletcher N., Clemence R., Blanchflower S., Brayden D.J. Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein. J. Vet. Pharmacol. Ther. 2005, 28:257-265.
72. Hattinger C.M., Stoico G., Michelacci F., Pasello M., Scionti I., Remondini D., Castellani G.C., Fanelli M., Scotlandi K., Picci P., Serra M. Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines. Genes Chromosomes Cancer 2009, 48:289-309.
73. Hennessy D.R., Alvinerie M.R. Pharmacocinetics of the macrocyclic lactones: conventional wisdom and new paradigms. Macrocyclic Lactones and Antiparasitic Therapy 2002, 97-123. CAB International. J. Vercruysse, R.S. Rew (Eds.).
74. Hibbs R.E., Gouaux E. Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature 2011, 474:54-60.
75. Hoffmeyer S., Burk O., von Richter O., Arnold H.P., Brockmoller J., Johne A., Cascorbi I., Gerloff T., Roots I., Eichelbaum M., Brinkmann U. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci. USA 2000, 97:3473-3478.
76. Hong H., Lu Y., Ji Z.N., Liu G.Q. Up-regulation of P-glycoprotein expression by glutathione depletion-induced oxidative stress in rat brain microvessel endothelial cells. J. Neurochem. 2006, 98:1465-1473.
77. Hotez P.J. Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases. Clin. Pharmacol. Ther. 2009, 85:659-664.
78. Hotez P.J., Molyneux D.H., Fenwick A., Kumaresan J., Sachs S.E., Sachs J.D., Savioli L. Control of neglected tropical diseases. N. Engl. J. Med. 2007, 357:1018-1027.
79. Hotez P.J., Brindley P.J., Bethony J.M., King C.H., Pearce E.J., Jacobson J. Helminth infections: the great neglected tropical diseases. J. Clin. Invest. 2008, 118:1311-1321.
80. Huang Y.J., Prichard R.K. Identification and stage-specific expression of two putative P-glycoprotein coding genes in Onchocerca volvulus. Mol. Biochem. Parasitol. 1999, 102:273-281.
81. Hugnet C., Lespine A., Alvinerie M. Multiple oral dosing of ketoconazole increases dog exposure to ivermectin. J. Pharm. Pharm. Sci. 2007, 10:311-318.
82. Huo H., Magro P.G., Pietsch E.C., Patel B.B., Scotto K.W. Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance. Cancer Res. 2010, 70:8726-8735.
83. James C.E., Davey M.W. Increased expression of ABC transport proteins is associated with ivermectin resistance in the model nematode Caenorhabditis elegans. Int. J. Parasitol. 2009, 39:213-220.
84. Jani M., Makai I., Kis E., Szabo P., Nagy T., Krajcsi P., Lespine A. Ivermectin interacts with human ABCG2. J. Pharm. Sci. 2010, 100:94-97.
85. Jin S., Scotto K.W. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol. Cell Biol. 1998, 18:4377-4384.
86. Johnson D.J., Owen A., Plant N., Bray P.G., Ward S.A. Drug-regulated expression of Plasmodium falciparum P-glycoprotein homologue 1: a putative role for nuclear receptors. Antimicrob. Agents Chemother. 2008, 52:1438-1445.
87. Jonker J.W., Smit J.W., Brinkhuis R.F., Maliepaard M., Beijnen J.H., Schellens J.H., Schinkel A.H. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J. Natl. Cancer Inst. 2000, 92:1651-1656.
88. Jonker J.W., Merino G., Musters S., van Herwaarden A.E., Bolscher E., Wagenaar E., Mesman E., Dale T.C., Schinkel A.H. The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk. Nat. Med. 2005, 11:127-129.
89. Kaminsky R., Ducray P., Jung M., Clover R., Rufener L., Bouvier J., Weber S.S., Wenger A., Wieland-Berghausen S., Goebel T., Gauvry N., Pautrat F., Skripsky T., Froelich O., Komoin-Oka C., Westlund B., Sluder A., Maser P. A new class of anthelmintics effective against drug-resistant nematodes. Nature 2008, 452:176-180.
90. Kaplan R.M. Drug resistance in nematodes of veterinary importance: a status report. Trends Parasitol. 2004, 20:477-481.
91. Karwatsky J., Lincoln M.C., Georges E. A mechanism for P-glycoprotein-mediated apoptosis as revealed by verapamil hypersensitivity. Biochemistry 2003, 42:12163-12173.
92. Keiser J., Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA 2008, 299:1937-1948.
93. Kerboeuf D., Guegnard F. Anthelmintics are substrates and activators of nematode P glycoprotein. Antimicrob. Agents Chemother. 2011, 55:2224-2232.
94. Kiki-Mvouaka S., Menez C., Borin C., Lyazrhi F., Foucaud-Vignault M., Dupuy J., Collet X., Alvinerie M., Lespine A. Role of P-glycoprotein in the disposition of macrocyclic lactones: a comparison between ivermectin, eprinomectin, and moxidectin in mice. Drug Metab. Dispos. 2010, 38:573-580.
95. Klaassen C.D., Slitt A.L. Regulation of hepatic transporters by xenobiotic receptors. Curr. Drug Metab. 2005, 6:309-328.
96. Korystov Y.N., Ermakova N.V., Kublik L.N., Levitman M., Shaposhnikova V.V., Mosin V.A., Drinyaev V.A., Kruglyak E.B., Novik T.S., Sterlina T.S. Avermectins inhibit multidrug resistance of tumor cells. Eur. J. Pharmacol. 2004, 493:57-64.
97. Krishnamurthy P., Schuetz J.D. Role of ABCG2/BCRP in biology and medicine. Annu. Rev. Pharmacol. Toxicol. 2006, 46:381-410.
98. Kwa M.S., Veenstra J.G., Roos M.H. Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in beta-tubulin isotype 1. Mol. Biochem. Parasitol. 1994, 63:299-303.
99. Kwa M.S., Veenstra J.G., Van Dijk M., Roos M.H. Beta-tubulin genes from the parasitic nematode Haemonchus contortus modulate drug resistance in Caenorhabditis elegans. J. Mol. Biol. 1995, 246:500-510.
100. Kwei G.Y., Alvaro R.F., Chen Q., Jenkins H.J., Hop C.E., Keohane C.A., Ly V.T., Strauss J.R., Wang R.W., Wang Z., Pippert T.R., Umbenhauer D.R. Disposition of ivermectin and cyclosporin A in CF-1 mice deficient in mdr1a P-glycoprotein. Drug Metab. Dispos. 1999, 27:581-587.
101. Laffont C.M., Toutain P.L., Alvinerie M., Bousquet-Melou A. Intestinal secretion is a major route for parent ivermectin elimination in the rat. Drug Metab. Dispos. 2002, 30:626-630.
102. Le Jambre L.F., Lenane I.J., Wardrop A.J. A hybridisation technique to identify anthelmintic resistance genes in Haemonchus. Int. J. Parasitol. 1999, 29:1979-1985.
103. Lee C.H., Bradley G., Ling V. Overexpression of the class II P-glycoprotein gene in primary rat hepatocyte culture: evidence for increased mRNA stability. Cell Growth Differ. 1995, 6:347-354.
104. Lee C.H., Bradley G., Ling V. Increased P-glycoprotein messenger RNA stability in rat liver tumors in vivo. J. Cell. Physiol. 1998, 177:1-12.
105. Lespine A., Dupuy J., Orlowski S., Nagy T., Glavinas H., Krajcsi P., Alvinerie M. Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3). Chem. Biol. Interact. 2006, 159:169-179.
106. Lespine A., Martin S., Dupuy J., Roulet A., Pineau T., Orlowski S., Alvinerie M. Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship. Eur. J. Pharm. Sci. 2007, 30:84-94.
107. Lespine A., Alvinerie M., Vercruysse J., Prichard R.K., Geldhof P. ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics. Trends Parasitol. 2008, 24:293-298.
108. Lifschitz A., Virkel G., Sallovitz J., Imperiale F., Pis A., Lanusse C. Loperamide-induced enhancement of moxidectin availability in cattle. J. Vet. Pharmacol. Ther. 2002, 25:111-120.
109. Lifschitz A.L., Virkel G.L., Sallovitz J.M., Pis A., Imperiale F.A., Lanusse C.E. Loperamide modifies the tissue disposition kinetics of ivermectin in rats. J. Pharm. Pharmacol. 2004, 56:61-67.
110. Lifschitz A., Virkel G., Ballent M., Sallovitz J., Lanusse C. Combined use of ivermectin and triclabendazole in sheep: in vitro and in vivo characterisation of their pharmacological interaction. Vet. J. 2009, 182:261-268.
111. Lifschitz A., Entrocasso C., Alvarez L., Lloberas M., Ballent M., Manazza G., Virkel G., Borda B., Lanusse C. Interference with P-glycoprotein improves ivermectin activity against adult resistant nematodes in sheep. Vet. Parasitol. 2010, 172:291-298.
112. Lifschitz A., Suarez V.H., Sallovitz J., Cristel S.L., Imperiale F., Ahoussou S., Schiavi C., Lanusse C. Cattle nematodes resistant to macrocyclic lactones: comparative effects of P-glycoprotein modulation on the efficacy and disposition kinetics of ivermectin and moxidectin. Exp. Parasitol. 2010, 125:172-178.
113. Lima R.M., Ferreira M.A., de Jesus Ponte Carvalho T.M., Dumet Fernandes B.J., Takayanagui O.M., Garcia H.H., Coelho E.B., Lanchote V.L. Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity. Br. J. Clin. Pharmacol. 2011, 71:528-535.
114. Lindblom T.H., Dodd A.K. Xenobiotic detoxification in the nematode Caenorhabditis elegans. J. Exp. Zoolog. A Comp. Exp. Biol. 2006, 305:720-730.
115. Lindblom T.H., Pierce G.J., Sluder A.E. A C. elegans orphan nuclear receptor contributes to xenobiotic resistance. Curr. Biol. 2001, 11:864-868.
116. Lubega G.W., Prichard R.K. Specific interaction of benzimidazole anthelmintics with tubulin: high-affinity binding and benzimidazole resistance in Haemonchus contortus. Mol. Biochem. Parasitol. 1990, 38:221-232.
117. Maglich J.M., Parks D.J., Moore L.B., Collins J.L., Goodwin B., Billin A.N., Stoltz C.A., Kliewer S.A., Lambert M.H., Willson T.M., Moore J.T. Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J. Biol. Chem. 2003, 278:17277-17283.
118. Martin R.J. Modes of action of anthelmintic drugs. Vet. J. 1997, 154:11-34.
119. Martin R.J., Robertson A.P. Mode of action of levamisole and pyrantel, anthelmintic resistance, E153 and Q57. Parasitology 2007, 134:1093-1104.
120. Martinez-Valladares M., Cordero-Perez C., Castanon-Ordonez L., Famularo M.R., Fernandez-Pato N., Rojo-Vazquez F.A. Efficacy of a moxidectin/triclabendazole oral formulation against mixed infections of Fasciola hepatica and gastrointestinal nematodes in sheep. Vet. Parasitol. 2010, 174:166-169.
121. McKellar Q.A., Scott E.W. The benzimidazole anthelmintic agents - a review. J. Vet. Pharmacol. Ther. 1990, 13:223-247.
122. Mealey K.L., Bentjen S.A., Gay J.M., Cantor G.H. Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 2001, 11:727-733.
123. Ménez, C, Mselli-Lakhal, L, Foucaud-Vignault, M, Alvinerie, M, Lespine, A., 2011. Ivermectin induces P-glycoprotein expression and function through mRNA stabilization in murine hepatocyte cell line. Biochem Pharmacol. Oct 18.
124. Merino G., Jonker J.W., Wagenaar E., Pulido M.M., Molina A.J., Alvarez A.I., Schinkel A.H. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2). Drug Metab. Dispos. 2005, 33:614-618.
125. Messerli S.M., Kasinathan R.S., Morgan W., Spranger S., Greenberg R.M. Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility. Mol. Biochem. Parasitol. 2009, 167:54-59.
126. Molento M.B., Prichard R.K. Effects of the multidrug-resistance-reversing agents verapamil and CL 347, 099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds (Meriones unguiculatus). Parasitol. Res. 1999, 85:1007-1011.
127. Molento M.B., Lifschitz A., Sallovitz J., Lanusse C., Prichard R. Influence of verapamil on the pharmacokinetics of the antiparasitic drugs ivermectin and moxidectin in sheep. Parasitol Res. 2004, 92:121-127.
128. Molyneux D.H., Bradley M., Hoerauf A., Kyelem D., Taylor M.J. Mass drug treatment for lymphatic filariasis and onchocerciasis. Trends Parasitol. 2003, 19:516-522.
129. Mottier M., Prichard R.K. Genetic analysis of a relationship between macrocyclic lactone and benzimidazole anthelmintic selection on Haemonchus contortus. Pharmacogenet. Genomics 2008, 18:129-140.
130. Mottier L., Alvarez L., Fairweather I., Lanusse C. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect. J. Parasitol. 2006, 92:1355-1360.
131. Muenster U., Grieshop B., Ickenroth K., Gnoth M.J. Characterization of substrates and inhibitors for the in vitro assessment of Bcrp mediated drug-drug interactions. Pharm. Res. 2008, 25:2320-2326.
132. Nare B., Liu Z., Prichard R.K., Georges E. Benzimidazoles, potent anti-mitotic drugs: substrates for the P-glycoprotein transporter in multidrug-resistant cells. Biochem. Pharmacol. 1994, 48:2215-2222.
133. Nies A.T., Jedlitschky G., Konig J., Herold-Mende C., Steiner H.H., Schmitt H.P., Keppler D. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 2004, 129:349-360.
134. Nobili S., Landini I., Giglioni B., Mini E. Pharmacological strategies for overcoming multidrug resistance. Curr. Drug Targets 2006, 7:861-879.
135. Orlowski S., Martin S., Escargueil A. P-glycoprotein and 'lipid rafts': some ambiguous mutual relationships (floating on them, building them or meeting them by chance?). Cell. Mol. Life Sci. 2006, 63:1038-1059.
136. Osei-Atweneboana M.Y., Eng J.K., Boakye D.A., Gyapong J.O., Prichard R.K. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 2007, 369:2021-2029.
137. Osei-Atweneboana M.Y., Awadzi K., Attah S.K., Boakye D.A., Gyapong J.O., Prichard R.K. Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus. PLoS Negl. Trop. Dis. 2011, 5:e998.
138. Pajic M., Iyer J.K., Kersbergen A., van der Burg E., Nygren A.O., Jonkers J., Borst P., Rottenberg S. Moderate increase in Mdr1a/1b expression causes in vivo resistance to doxorubicin in a mouse model for hereditary breast cancer. Cancer Res. 2009, 69:6396-6404.
139. Pal A., Mehn D., Molnar E., Gedey S., Meszaros P., Nagy T., Glavinas H., Janaky T., von Richter O., Bathori G., Szente L., Krajcsi P. Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2. J. Pharmacol. Exp. Ther. 2007, 321:1085-1094.
140. Perez M., Blazquez A.G., Real R., Mendoza G., Prieto J.G., Merino G., Alvarez A.I. In vitro and in vivo interaction of moxidectin with BCRP/ABCG2. Chem. Biol. Interact. 2009, 180:106-112.
141. Pouliot J.F., L'Heureux F., Liu Z., Prichard R.K., Georges E. Reversal of P-glycoprotein-associated multidrug resistance by ivermectin. Biochem. Pharmacol. 1997, 53:17-25.
142. Prichard R. Ivermectin resistance and overview of the consortium for anthelmintic resistance. Expert Opin. Drug Discov. 2007, 2:41-52.
143. Prichard R.K., Roulet A. ABC transporters and beta-tubulin in macrocyclic lactone resistance: prospects for marker development. Parasitology 2007, 134:1123-1132.
144. Prouillac C., Lecoeur S. The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies. Drug Metab. Dispos. 2010, 38:1623-1635.
145. Pulido M.M., Molina A.J., Merino G., Mendoza G., Prieto J.G., Alvarez A.I. Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep. J. Vet. Pharmacol. Ther. 2006, 29:279-287.
146. Qian H., Martin R.J., Robertson A.P. Pharmacology of N-, L-, and B-subtypes of nematode nAChR resolved at the single-channel level in Ascaris suum. FASEB J. 2006, 20:2606-2608.
147. Rao V.V., Dahlheimer J.L., Bardgett M.E., Snyder A.Z., Finch R.A., Sartorelli A.C., Piwnica-Worms D. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc. Natl. Acad. Sci. USA 1999, 96:3900-3905.
148. *) from Haemonchus contortus is expressed in the cervical papillae and is associated with macrocyclic lactone resistance. Mol. Biochem. Parasitol. 2009, 166:54-61.
149. Real R., Egido E., Perez M., Gonzalez-Lobato L., Barrera B., Prieto J.G., Alvarez A.I., Merino G. Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: interaction with ivermectin. J. Vet. Pharmacol. Ther. 2011, 34:313-321.
150. Reed K., Hembruff S.L., Sprowl J.A., Parissenti A.M. The temporal relationship between ABCB1 promoter hypomethylation, ABCB1 expression and acquisition of drug resistance. Pharmacogenomics J. 2010, 10:489-504.
151. Riou M., Guegnard F., Le Vern Y., Kerboeuf D. Modulation of the multidrug resistance (MDR) system in the nematode Haemonchus contortus by changing cholesterol content: effects on resistance to anthelmintics. J. Antimicrob. Chemother. 2003, 52:180-187.
152. Riou M., Koch C., Delaleu B., Berthon P., Kerboeuf D. Immunolocalisation of an ABC transporter, P-glycoprotein, in the eggshells and cuticles of free-living and parasitic stages of Haemonchus contortus. Parasitol. Res. 2005, 96:142-148.
153. Riou M., Guegnard F., Sizaret P.Y., Le Vern Y., Kerboeuf D. Drug resistance is affected by colocalization of P-glycoproteins in raft-like structures unexpected in eggshells of the nematode Haemonchus contortus. Biochem. Cell Biol. 2010, 88:459-467.
154. Rothwell J., Sangster N. Haemonchus contortus: the uptake and metabolism of closantel. Int. J. Parasitol. 1997, 27:313-319.
155. Roulet A., Puel O., Gesta S., Lepage J.F., Drag M., Soll M., Alvinerie M., Pineau T. MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin. Eur. J. Pharmacol. 2003, 460:85-91.
156. Rufener L., Maser P., Roditi I., Kaminsky R. Haemonchus contortus acetylcholine receptors of the DEG-3 subfamily and their role in sensitivity to monepantel. PLoS Pathog. 2009, 5:e1000380.
157. Sangster N.C., Bannan S.C., Weiss A.S., Nulf S.C., Klein R.D., Geary T.G. Haemonchus contortus: sequence heterogeneity of internucleotide binding domains from P-glycoproteins. Exp. Parasitol. 1999, 91:250-257.
158. Sarkadi B., Homolya L., Szakacs G., Varadi A. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol. Rev. 2006, 86:1179-1236.
159. Sartor L.L., Bentjen S.A., Trepanier L., Mealey K.L. Loperamide toxicity in a collie with the MDR1 mutation associated with ivermectin sensitivity. J. Vet. Intern. Med. 2004, 18:117-118.
160. Schinkel A.H., Smit J.J., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., Mol C.A., van der Valk M.A., Robanus-Maandag E.C., te Riele H.P., et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994, 77:491-502.
161. Schinkel A.H., Wagenaar E., Mol C.A., van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest. 1996, 97:2517-2524.
162. Schrenk D., Baus P.R., Ermel N., Klein C., Vorderstemann B., Kauffmann H.M. Up-regulation of transporters of the MRP family by drugs and toxins. Toxicol. Lett. 2001, 120:51-57.
163. Seelig A., Gerebtzoff G. Enhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein binding. Expert Opin. Drug Metab. Toxicol. 2006, 2:733-752.
164. Seral C., Carryn S., Tulkens P.M., Van Bambeke F. Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus. J. Antimicrob. Chemother. 2003, 51:1167-1173.
165. Sheps J.A., Ralph S., Zhao Z., Baillie D.L., Ling V. The ABC transporter gene family of Caenorhabditis elegans has implications for the evolutionary dynamics of multidrug resistance in eukaryotes. Genome Biol. 2004, 5:R15.
166. Sherman J.G., Paul A.J., Firkins L.D. Evaluation of the safety of spinosad and milbemycin 5-oxime orally administered to Collies with the MDR1 gene mutation. Am. J. Vet. Res. 2010, 71:115-119.
167. Silvestre A., Cabaret J. Mutation in position 167 of isotype 1 beta-tubulin gene of Trichostrongylid nematodes: role in benzimidazole resistance?. Mol. Biochem. Parasitol. 2002, 120:297-300.
168. Smith J.M., Prichard R.K. Localization of p-glycoprotein mRNA in the tissues of Haemonchus contortus adult worms and its relative abundance in drug-selected and susceptible strains. J. Parasitol. 2002, 88:612-620.
169. Staudinger J.L., Madan A., Carol K.M., Parkinson A. Regulation of drug transporter gene expression by nuclear receptors. Drug Metab. Dispos. 2003, 31:523-527.
170. Stein U., Walther W., Wunderlich V. Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs. Eur. J. Cancer 1994, 30A:1541-1545.
171. Stepek G., Buttle D.J., Duce I.R., Behnke J.M. Human gastrointestinal nematode infections: are new control methods required?. Int. J. Exp. Pathol. 2006, 87:325-341.
172. Synold T.W., Dussault I., Forman B.M. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat. Med. 2001, 7:584-590.
173. Szakacs G., Paterson J.K., Ludwig J.A., Booth-Genthe C., Gottesman M.M. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 2006, 5:219-234.
174. Tribble N.D., Burka J.F., Kibenge F.S. Evidence for changes in the transcription levels of two putative P-glycoprotein genes in sea lice (Lepeophtheirus salmonis) in response to emamectin benzoate exposure. Mol. Biochem. Parasitol. 2007, 153:59-65.
175. Virkel G., Lifschitz A., Sallovitz J., Pis A., Lanusse C. Comparative hepatic and extrahepatic enantioselective sulfoxidation of albendazole and fenbendazole in sheep and cattle. Drug Metab. Dispos. 2004, 32:536-544.
176. Vlaming M.L., Lagas J.S., Schinkel A.H. Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice. Adv. Drug Deliv. Rev. 2009, 61:14-25.
177. Wei P., Zhang J., Egan-Hafley M., Liang S., Moore D.D. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 2000, 407:920-923.
178. Welz C., Kruger N., Schniederjans M., Miltsch S.M., Krucken J., Guest M., Holden-Dye L., Harder A., von Samson-Himmelstjerna G. SLO-1-channels of parasitic nematodes reconstitute locomotor behaviour and emodepside sensitivity in Caenorhabditis elegans slo-1 loss of function mutants. PLoS Pathog. 2011, 7:e1001330.
179. Williamson, S.M., Wolstenholme, A.J., 2011. P-glycoproteins of Haemonchus contortus: development of real-time PCR assays for gene expression studies. J Helminthol. Jun 1:1-7.
180. Williamson S.M., Coles G.C., McCaverna S., Wolstenholme A.J. Investigating candidate resistance genes in an ivermectin-resistant isolate of Haemonchus contortus 2010, Annual meeting of the AAVP, Atlanta.
181. Williamson S.M., Storey B., Howell S., Harper K.M., Kaplan R.M., Wolstenholme A.J. Candidate anthelmintic resistance-associated gene expression and sequence polymorphisms in a triple-resistant field isolate of Haemonchus contortus. Mol Biochem Parasitol. 2011, 180(2):99-105.
182. Wolstenholme A.J., Rogers A.T. Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelmintics. Parasitology 2005, 131(Suppl.):S85-S95.
183. Wolstenholme A.J., Fairweather I., Prichard R., von Samson-Himmelstjerna G., Sangster N.C. Drug resistance in veterinary helminths. Trends Parasitol. 2004, 20:469-476.
184. Xu M., Molento M., Blackhall W., Ribeiro P., Beech R., Prichard R. Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Mol. Biochem. Parasitol. 1998, 91:327-335.
185. Yague E., Armesilla A.L., Harrison G., Elliott J., Sardini A., Higgins C.F., Raguz S. P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation. J. Biol. Chem. 2003, 278:10344-10352.
186. Zhao Z., Sheps J.A., Ling V., Fang L.L., Baillie D.L. Expression analysis of ABC transporters reveals differential functions of tandemly duplicated genes in Caenorhabditis elegans. J. Mol. Biol. 2004, 344:409-417.
187. Zhou S.F. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 2008, 38:802-832.
188. Zubovych I., Doundoulakis T., Harran P.G., Roth M.G. A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance. Proc. Natl. Acad. Sci. USA 2006, 103:15523-15528.